Coherus Oncology annual debt-to-assets ratio
2013
2018
2019
2020
2021
2022
2023
2024
2025
Coherus Oncology Debt-to-Assets Ratio Growth & History (CHRS)
Coherus Oncology's debt-to-assets ratio was 0.01 for fiscal 2025.
View full Coherus Oncology company overviewCoherus Oncology annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.01 | 0.00 | +14.59% |
| 2024 | 2024-12-31 | 0.01 | −0.00 | −6.51% |
| 2023 | 2023-12-31 | 0.01 | −0.01 | −39.05% |
| 2022 | 2022-12-31 | 0.02 | 0.00 | +23.14% |
| 2021 | 2021-12-31 | 0.02 | 0.00 | +1.75% |
| 2020 | 2020-12-31 | 0.02 | −0.20 | −92.62% |
| 2019 | 2019-12-31 | 0.21 | 0.21 | — |
| 2018 | 2018-12-31 | 0.00 | — | — |
| 2013 | 2013-12-31 | 0.02 | — | — |
Coherus Oncology quarterly debt-to-assets ratio
Q4.13
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q4.22
Q4.23
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.01 | −0.08 | −86.52% |
| Q1 2026 | 2026-03-31 | 0.15 | — | — |
| Q4 2025 | 2025-12-31 | 0.01 | 0.00 | +14.59% |
| Q3 2025 | 2025-09-30 | 0.08 | — | — |
| Q2 2025 | 2025-06-30 | 0.09 | — | — |
| Q4 2024 | 2024-12-31 | 0.01 | −0.00 | −6.51% |
| Q4 2023 | 2023-12-31 | 0.01 | −0.01 | −39.05% |
| Q4 2022 | 2022-12-31 | 0.02 | 0.00 | +23.14% |
| Q4 2021 | 2021-12-31 | 0.02 | 0.00 | +1.75% |
| Q3 2021 | 2021-09-30 | 0.11 | 0.09 | +536.78% |
| Q2 2021 | 2021-06-30 | 0.11 | 0.09 | +479.88% |
| Q1 2021 | 2021-03-31 | 0.13 | 0.10 | +359.47% |
| Q4 2020 | 2020-12-31 | 0.02 | −0.20 | −92.62% |
| Q3 2020 | 2020-09-30 | 0.02 | −0.02 | −56.39% |
| Q2 2020 | 2020-06-30 | 0.02 | −0.32 | −94.45% |
| Q1 2020 | 2020-03-31 | 0.03 | −0.41 | −93.37% |
| Q4 2019 | 2019-12-31 | 0.21 | 0.21 | — |
| Q3 2019 | 2019-09-30 | 0.04 | — | — |
| Q2 2019 | 2019-06-30 | 0.34 | — | — |
| Q1 2019 | 2019-03-31 | 0.44 | — | — |
| Q4 2018 | 2018-12-31 | 0.00 | — | — |
| Q4 2013 | 2013-12-31 | 0.02 | — | — |
Coherus Oncology debt-to-assets ratio trends
Over the last five fiscal years, Coherus Oncology's debt-to-assets ratio decreased from 0.02 to 0.01, a change of −0.00. The latest reported quarter, Q2 2026, shows 0.01.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Coherus Oncology source filings ↗